David R. Brenneman represents clients on the antitrust aspects of mergers and acquisitions (M&A), joint ventures, and other business combinations and has experience in a wide range of industries, including technology, telecommunications, life sciences, and financial services. David has coordinated premerger notifications and regulatory review around the world for hundreds of multimillion- and multibillion-dollar transactions. He has defended several high-profile transactions before the US Department of Justice (DOJ) Antitrust Division, US Federal Trade Commission (FTC), and European Commission, and has represented several investment management firms in connection with DOJ investigations under Section 8 of the Clayton Act.
David regularly counsels clients with respect to agency strategy and procedure; premerger conduct counseling; contract negotiations; merger control analysis, filings, and approvals; and substantive advocacy before various competition law authorities in the United States and abroad. David has guided clients through numerous DOJ and FTC investigations and second requests and has prepared Hart-Scott-Rodino (HSR) and other merger control filings for hundreds of transactions. David has also guided clients through investigations into possible Clayton Act Section 8 violations. He frequently writes on topics concerning merger review and the HSR Act and his writings have appeared in Law360, The M&A Lawyer, and various American Bar Association publications, among others.
David is a member of the Morgan Lewis Committee on Foreign Investment in the United States (CFIUS) Working Group.
David regularly represents some of the world’s largest private equity groups and other prominent companies in relation to merger control work. In addition, he has had leadership roles in obtaining antitrust approvals in several high- profile and complicated transactions, including:
Recommended, Antitrust: Merger control, The Legal 500 US (2018–2020, 2022)
Member, Practice Group of the Year, Competition, Law360 (2017–2021)
Member, Practice Group of the Year for Antitrust, US News & World Report and Best Lawyers (2017)